T&L Co., Ltd. (KOSDAQ:340570)

Market Cap	588.45B
Revenue (ttm)	174.89B
Net Income (ttm)	46.41B
Shares Out	8.07M
EPS (ttm)	5,749.19
PE Ratio	12.68
Forward PE	10.01
Dividend	750.00 (1.06%)
Ex-Dividend Date	Dec 27, 2024

Volume	39,084
Average Volume	49,417
Open	70,700
Previous Close	71,000
Day's Range	70,700 - 72,900
52-Week Range	50,400 - 85,600
Beta	0.27
RSI	50.38
Earnings Date	May 16, 2025

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1998
• Employees: 142
• Stock Exchange: KOSDAQ
• Ticker Symbol: 340570

Financial Performance

In 2024, T&L Co., Ltd.'s revenue was 174.89 billion, an increase of 51.47% compared to the previous year's 115.46 billion. Earnings were 46.41 billion, an increase of 69.13%.